Biomedical Engineering Reference
In-Depth Information
iron oxide nanoparticles and the implications for their in vivo clearance. Biomaterials
30:3926-3933
4. Vroman L, Adams AL, Fischer GC, Munoz PC (1980) Interaction of high molecular-weight
kininogen, factor-Xii, and fibrinogen in plasma at interfaces. Blood 55:156-159
5. Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE (2009) Nanoparticle
interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and
therapeutic efficacy. Adv Drug Deliv Rev 61:428-437
6. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA (2008) Nanoparticle size and
surface properties determine the protein corona with possible implications for biological
impacts. Proc Natl Acad Sci USA 105:14265-14270
7. Lynch I, Dawson KA (2008) Protein-nanoparticle interactions. Nano Today 3:40-47
8. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA (2008) Nanoparticle size and
surface properties determine the protein corona with possible implications for biological
impacts. Proc Natl Acad Sci USA 105:14265-14270
9. Karmali PP, Simberg D (2011) Interactions of nanoparticles with plasma proteins: implication
on clearance and toxicity of drug delivery systems. Expert Opin Drug Deliv 8:343-357
10. Gessner A, Waicz R, Lieske A, Paulke BR, M
¨
der K, M
¨
ller RH (2000) Nanoparticles with
decreasing surface hydrophobicities: influence on plasma protein adsorption. Int J Pharm
196:245-249
11. Lundqvist M, Stigler J, Cedervall T, Berggard T, Flanagan MB, Lynch I, Elia G, Dawson K
(2011) The evolution of the protein corona around nanoparticles: a test study. ACS Nano
5:7503-7509
12. Rocker C, Potzl M, Zhang F, Parak WJ, Nienhaus GU (2009) A quantitative fluorescence study
of protein monolayer formation on colloidal nanoparticles. Nat Nanotechnol 4:577-580
13. Dobrovolskaia MA, Patri AK, Zheng J, Clogston JD, Ayub N, Aggarwal P, Neun BW, Hall JB,
McNeil SE (2009) Interaction of colloidal gold nanoparticles with human blood: effects on
particle size and analysis of plasma protein binding profiles. Nanomedicine 5:106-117
14. Slack SM, Horbett TA (1995) The Vroman effect. ACS Symp Ser 602:112-128
15. Cedervall T, Lynch I, Lindman S, Berggard T, Thulin E, Nilsson H, Dawson KA, Linse S
(2007) Understanding the nanoparticle-protein corona using methods to quantify exchange
rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA 104:2050-2055
16. Goppert TM, Muller RH (2005) Polysorbate-stabilized solid lipid nanoparticles as colloidal
carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorp-
tion patterns. J Drug Target 13:179-187
17. Goppert TM, Muller RH (2005) Adsorption kinetics of plasma proteins on solid lipid
nanoparticles for drug targeting. Int J Pharm 302:172-186
18. Jansch M, Stumpf P, Graf C, Ruhl E, Muller RH (2012) Adsorption kinetics of plasma proteins
on ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles. Int J Pharm 428:125-133
19. Mahmoudi M, Lynch I, Ejtehadi MR, Monopoli MP, Bombelli FB, Laurent S (2011) Protein
nanoparticle interactions: opportunities and challenges. Chem Rev 111:5610-5637
20. Casals E, Pfaller T, Duschl A, Oostingh GJ, Puntes V (2010) Time evolution of the nanoparti-
cle protein corona. ACS Nano 4:3623-3632
21. Gessner A, Lieske A, Paulke BR, M
¨
ller RH (2002) Influence of surface charge density on
protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis.
Eur J Pharm Biopharm 54:165-170
22. Bradley AJ, Devine DV, Ansell SM, Janzen J, Brooks DE (1998) Inhibition of liposome-
induced complement activation by incorporated poly(ethylene glycol)-lipids. Arch Biochem
Biophys 357:185-194
23. Oku N, Tokudome Y, Namba Y, Saito N, Endo M, Hasegawa Y, Kawai M, Tsukada H, Okada
S (1996) Effect of serum protein binding on real-time trafficking of liposomes with different
charges analyzed by positron emission tomography. Biochim Biophys Acta 1280:149-154
24. Deng ZJ, Mortimer G, Schiller T, Musumeci A, Martin D, Minchin RF (2009) Differential
plasma protein binding to metal oxide nanoparticles. Nanotechnology 20:455101
